Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame
The Danish drugmaker also revealed an improved outlook for the year.
The Danish drugmaker also revealed an improved outlook for the year. This story matters for Finance & Markets readers tracking currency. Reported by marketwatch.com. Read the full original at the source link below.
Originally reported by marketwatch.com. CurrencyNews.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily currency signal